nach oben

Journal of Interventional Cardiac Electrophysiology

01.03.2013

Incorporating the patient perspective: a critical review of clinical practice guidelines for implantable cardioverter defibrillator therapy

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Implantable cardioverter defibrillators (ICDs) are recommended for patients with heart failure and/or ventricular arrhythmias at risk of sudden cardiac death. Guidelines for ICD implantation are derived from robust clinical data. However, critical factors which might influence treatment decisions include patient preferences. We set out to determine how clinical practice guidelines (CPGs) incorporate the patient perspective into supporting decision making about ICDs.

Methods

CPGs on ICD implantation were purposively selected from national and professional bodies in Europe, North America and Australasia. CPGs were then appraised according to three key domains of shared decision making: (a) informing patients about the risks, benefits and consequences known to be important to patients; (b) personalising risks and benefits and (c) involvement of patient (plus family/significant others if desired) in decision making.

Results

Appraisal of six current CPGs found major deficiencies or inconsistencies in guidance. CPGs tended to focus on evidence of device effectiveness, with sparse consideration of other outcomes important to patients such as impacts on quality of life and psychosocial well-being. Little reference was made to involvement of the patient in decision making.

Conclusions

This suggests that embedding shared decision in CPGs will improve the patient-centeredness of ICD treatment by enabling patients to make informed, value-based decisions. Specific recommendations for CPG development include the need for signposting to preference sensitive decision points as well as inclusion of a broader range of outcomes which are known to be important to patients when deciding whether or not to have a device fitted.

Sackett, D. L., Rosenberg, W. M. C., Gray, J. A. M., Haynes, R. B., & Richardson, W. S. (1996). Evidence-based medicine: what it is and what it isn’t. BMJ, 312, 71–72.

Institute of Medicine. (1990). In M. J. Field & K. N. Lohr (Eds.), Clinical practice guidelines: directions for a new program. Washington, DC: National Academy Press.

Stacey, D., Bennett, C. L., Barry, M. J., Col, N. F., Eden, K. B., Holmes-Rovner, M., et al. (2011). Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews, (10): p. Art. No.: CD001431.

Salzburg Global Seminar. (2011). Salzburg statement on shared decision making. BMJ, 342, d1745.CrossRef

Towle, A., & Godolphin, W. (1999). Framework for teaching and learning informed shared decision making. BMJ, 319, 766.PubMedCrossRef

O’Connor, A. M., Wennberg, J. E., Legare, F., Llewellyn-Thomas, H. A., Moulton, B. W., & Sepucha, K. R. (2007). Toward the “tipping point”: decision aids and informed patient choice. Health Affairs (Millwood), 26, 716–725.CrossRef

Elwyn, G., Laitner, S., Coulter, A., Walker, E., Watson, P., & Thomson, R. (2010). Implementing shared decision making in the NHS. BMJ, 341, c5146.PubMedCrossRef

Godolphin, W. (2003). The role of risk communication in shared decision making. BMJ, 327, 692.PubMedCrossRef

Edwards, A., Elwyn, G., Atwell, C., Hood, K., Houston, H., & Kinnersley, P. (2004). Patient-based outcome results from a cluster randomised trial of shared decision making skill development and use of risk communication aids in general practice. Family Practice, 21, 347–354.PubMedCrossRef

10.

Alonso-Coello, P., Montori, V. M., Sola, I., Schünemann, H. J., Devereaux, P. J., Charelese, C., et al. (2008). Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians’ and patients’ perspectives: protocol for a two-phase study. BMC Health Services Research, 8, 221.PubMedCrossRef

11.

Grol, R., & van Weel, C. (2009). Getting a grip on guidelines: how to make them more relevant for practice. British Journal of General Practice, 59, 322–328.CrossRef

12.

van der Weijden, T., Légaré, F., Boivin, A., Burgers, J. S., van Veenendaal, H., Stiggelbout, A. M., et al. (2010). How to integrate individual patient values and preferences in clinical practice guidelines? A research protocol. Implementation Science, 5, 10.PubMedCrossRef

13.

Thomson, R. G., Parkin, D., Eccles, M., Sudlow, M., & Robinson, A. (2000). Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet, 355, 956–962.PubMedCrossRef

14.

Boivin, A., Currie, K., Fervers, B., Gracia, J., James, M., Marshall, C., et al. (2010). Patient and public involvement in clinical guidelines: international experiences and future perspectives. Quality & Safety in Health Care, 19(5), e22.CrossRef

15.

National Institute for Health and Clinical Excellence. (2009). Early and locally advanced breast cancer: diagnosis and treatment. (NICE clinical guideline no. 80). London: National Collaborating Centre for Cancer.

16.

Galla, J. H. (2000). Clinical practice guideline on shared decision-making in the appropriate initiation of and withdrawal from dialysis. Journal of the American Society of Nephrology, 11, 1340–1342.PubMed

17.

Brindis, R., & Spertus, J. A. (2010). Employing shared decision-making models to improve care and patient value: a cardiovascular professional initiative. Journal of the American College of Cardiology, 56(24), 2046–2048.PubMedCrossRef

18.

Walsh, M. N., Bove, A. A., Cross, R. R., Ferdinand, K. C., Forman, D. E., Freeman, A. M., et al. (2012). ACCF 2012 health policy statement on patient-centred care in cardiovascular medicine. Journal of the American College of Cardiology, 59(23), 2125–2143.PubMedCrossRef

19.

Allen, L. A., Stevenson, L. W., Grady, K. L., Goldstein, N. E., Matlock, D. D., Arnold, R. M., et al. (2012). Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation, 125(15), 1928–1952.PubMedCrossRef

20.

Redhead, A. P., Turkington, D., Rao, S., Tynan, M. M., & Bourke, J. P. (2010). Psychopathology in postinfarction patients implanted with cardioverter-defibrillators for secondary prevention. A cross-sectional, case-controlled study. Journal of Psychosomatic Research, 69(6), 555–563.PubMedCrossRef

21.

Mark, D. B., Anstrom, K. J., Sun, J. L., Clapp-Channing, N. E., Tsiatis, A. A., Davidson-Ray, L., et al. (2008). Sudden cardiac death in heart failure trial investigators, quality of life with defibrillator therapy or amiodarone in heart failure. New England Journal of Medicine, 359, 999–1008.PubMedCrossRef

22.

Nazarian, S., Maisel, W. H., Miles, J. S., Tsang, S., Stevenson, L. W., & Stevenson, W. G. (2005). Impact of implantable cardioverter defibrillators on survival and recurrent hospitalization in advanced heart failure. American Heart Journal, 150, 955–960.PubMedCrossRef

23.

Matlock, D. D., Nowels, C. T., Masoudi, F. A., Sauer, W. H., Bekelman, D. B., Main, D. S., et al. (2011). Patient and cardiologist perceptions on decision making for implantable cardioverter-defibrillators: a qualitative study. Pacing and Clinical Electrophysiology, 34(12), 1634–1644.PubMedCrossRef

24.

Langseth, M. S., Shepherd, E., Thomson, R., & Lord, S. (2012). Quality of decision making is related to decision outcome for patients with cardiac arrhythmia. Patient Education and Counseling, 87, 49–53.PubMedCrossRef

25.

Stevenson, L. W., & Desai, A. S. (2006). Selecting patients for discussion of the ICD as primary prevention for sudden death in heart failure. Journal of Cardiac Failure, 12(6), 407–412.PubMedCrossRef

26.

Al-Khatib, S., Hellkamp, A., Curtis, J., Mark, D., Peterson, E., Sanders, G. D., et al. (2011). Non-evidence-based ICD implantations in the United States. Journal of the American Medical Association, 305(1), 43–49.

27.

Matlock, D. D., Peterson, P. N., Heidenreich, P. A., Lucas, F. L., Malenka, D. J., Wang, Y., et al. (2011). Regional variation in the use of implantable cardioverter-defibrillators for primary prevention: results from the National Cardiovascular Data Registry. Circulation. Cardiovascular Quality and Outcomes, 4(1), 114–121.

28.

McComb, J. M., Plummer, C. J., Cunningham, M. W., & Cunningham, D. (2009). Inequity of access to implantable cardioverter defibrillator therapy in England: possible causes of geographical variation in implantation rates. Europace, 11, 1308–1312.PubMedCrossRef

29.

Epstein, A. E., DiMarco, J. P., Ellenbogen, K. A., Estes, N. A. 3rd, Freedman, R. A., Gettes, L. S., et al. (2008). ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation, 117(21), e350–e408.

30.

Tang, A. S., Ross, H., Simpson, C. S., Mitchell, L. B., Dorian, P., Goeree, R., et al. (2005). Canadian Cardiovascular Society/Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada. Canadian Journal of Cardiology, 21(Suppl A), 11A–18A.PubMed

31.

Hauer, R. N. W., Aliot, E., Block, M., Capucci, A., Lüderitz, B., Santini, M., et al. (2001). Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology. European Heart Journal, 22, 1074–1081.

32.

National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand (Chronic Heart Failure Guidelines Expert Writing Panel), Guidelines for the prevention, detection and management of chronic heart failure in Australia. Updated October 2011.

33.

National Institute for Health and Clinical Excellence (2006). Implantable Cardioverter Defibrillators for arrhythmias.

34.

Scottish Intercollegiate Guidelines Network, Cardiac arrhythmias in coronary heart disease. A national clinical guideline, S.I.G. Network, Editor 2007: Edinburgh.

35.

Dickstein, K., Vardas, P. E., Auricchio, A., Daubert, J.-C., Linde, C., McMurray, J., et al. (2010). Focused update of ESC guidelines on device therapy in heart failure. European Heart Journal, 31(21), 2677–2687.

36.

Pettit, S. J., Browne, S., Hogg, K. J., Connelly, D. T., Gardner, R. S., May, C. R., et al. (2012). ICDs in end-stage heart failure. BMJ Supportive and Palliative Care, 2, 94–97.CrossRef

37.

O'Connor, A. M., Légaré, F., & Stacey, D. (2003). Risk communication in practice: the contribution of decision aids. BMJ, 327, 736–740.PubMedCrossRef

38.

Van Den Broek, K. C., Habibović, M., & Pedersen, S. S. (2010). Emotional distress in partners of patients with an implantable cardioverter defibrillator: a systematic review and recommendations for future research. Pacing and Clinical Electrophysiology, 33(12), 1442–1450.CrossRef

39.

Sears, S. F., & Conti, J. B. (2002). Quality of life and psychological functioning of ICD patients. Heart, 87, 488–493.PubMedCrossRef

40.

Sears, S. F., Hauf, J. D., Kirian, K., Hazelton, G., & Conti, J. B. (2011). Posttraumatic stress and the implantable cardioverter-defibrillator patient: what the electrophysiologist needs to know. Circulation. Arrhythmia and Electrophysiology, 4, 242–250.PubMedCrossRef

41.

Mühlhauser, I. (2010). From authority recommendations to fact-sheets—a future for guidelines. Diabetologia, 53, 2285–2288.PubMedCrossRef

42.

Hegarty, K., Gunn, J., Blashki, G., Griffiths, F., Dowell, T., & Kendrick, T. (2009). How could depression guidelines be made more relevant and applicable to primary care? British Journal of General Practice, 59, 322–328.

43.

Johansson, I., & Strömberg, A. (2010). Experiences of driving and driving restrictions in recipients with an implantable cardioverter defibrillator—the patient perspective. Journal of Cardiovascular Nursing, 25(6), E1–E10.PubMed

44.

Lemon, J., Edelman, S., & Kirkness, A. (2004). Avoidance behaviour in patients with implantable cardioverter defibrillators. Heart & Lung, 33, 176–182.CrossRef

45.

Bostwick, J. M., & Sola, C. L. (2011). An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life. Heart Failure Clinics, 7(1), 101–108.PubMedCrossRef

46.

van der Weijden, B. A., Burgers, J., Schunemann, H. J., & Elwyn, G. (2012). Clinical practice guidelines and patient decision aids. An inevitable relationship. Journal of Clinical Epidemiology, 65(6), 584–589.PubMedCrossRef

47.

Gigerenzer, G. (2002). How innumeracy can be exploited, in Reckoning with risk—learning to live with uncertainty (pp. 201–210). London: Penguin Press.

48.

Elwyn, G., O'Connor, A. M., Bennett, C., Newcombe, R. G., Politi, M., Durand, M., et al. (2009). Assessing the quality of decision support technologies using the International Patient Decision Aid Standards instrument (IPDASi). PLoS One, 4(3), e4705.

49.

Stiggelbout, A. M., van der Weijden, T., De Wit, M. P. T., Frosch, D., Légaré, F., Montori, V. M., et al. (2012). Shared decision making: really putting patients at the centre of healthcare. BMJ, 344, e256.PubMedCrossRef

50.

Option grids. Available from: http://www.optiongrid.co.uk/. Accessed 28 Aug 2012.

51.

Joosten, E. A., Defuentes-Merillas, L., de Weert, G. H., Sensky, T., van der Staak, C. P., & de Jong, C. A. (2008). Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychotherapy and Psychosomatics, 77, 219–226.

52.

Mulley, A. G. Learning from variations to increase value for money in the NHS. Available from: http://www.kingsfund.org.uk/blog/health_variations.html. 5 Aug 2011.

53.

Coulter, A. (1997). Partnerships with patients: the pros and cons of shared clinical decision-making. Journal of Health Services Research & Policy, 2(2), 112–121.

54.

Thomson, R., Murtagh, M., & Khaw, F. M. (2005). Tensions in public health policy: patient engagement, evidence-based public health and health inequalities. Quality & Safety in Health Care, 14(6), 398–400.CrossRef

55.

Henry, M. S. (2006). Uncertainty, responsibility, and the evolution of the physician/patient relationship. Journal of Medical Ethics, 32, 321–323.PubMedCrossRef

56.

Say, R. E., & Thomson, R. (2003). The importance of patient preferences in treatment decisions—challenges for doctors. BMJ, 327, 542.PubMedCrossRef

57.

Radina, M. E., Ginter, A. C., Brandt, J., Swaney, J., & Longo, D. R. (2011). Breast cancer patients’ use of health information in decision making and coping. Cancer Nursing, 34(5), E1–E12.PubMedCrossRef

58.

Adams, J. R., & Drake, R. E. (2006). Shared decision-making and evidence-based practice. Community Mental Health Journal, 42(1), 87–105.PubMedCrossRef

Titel: Incorporating the patient perspective: a critical review of clinical practice guidelines for implantable cardioverter defibrillator therapy
Publikationsdatum: 01.03.2013
Erschienen in: Journal of Interventional Cardiac Electrophysiology / Ausgabe 2/2013
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI: https://doi.org/10.1007/s10840-012-9762-6

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen